Page last updated: 2024-08-23

etoposide and Carcinoma, Squamous Cell

etoposide has been researched along with Carcinoma, Squamous Cell in 272 studies

Research

Studies (272)

Timeframe	Studies, this research(%)	All Research%
pre-1990	63 (23.16)	18.7374
1990's	105 (38.60)	18.2507
2000's	57 (20.96)	29.6817
2010's	43 (15.81)	24.3611
2020's	4 (1.47)	2.80

Authors

Authors	Studies
Mimaki, Y; Sakagami, H; Sashida, Y; Yokosuka, A	1
Kuroda, M; Mimaki, Y; Sakagami, H; Sashida, Y	1
Aoshima, T; Haraguchi, M; Kuroda, M; Mimaki, Y; Sakagami, H; Young, MC	1
Amar, L; Gantchev, J; Gill, RPK; Guerra Ordaz, DJ; Lambert, M; Lefrançois, P; Litvinov, IV; Martínez Villarreal, A; Messina-Pacheco, J; Ramchatesingh, B; Raveendra, K; Sikorski, D; Xie, P; Xu, HH	1
Althouse, S; Anouti, B; Durm, G; Hanna, N	1
Lomma, C; Ransom, D	1
Hiroshima, K; Ikeda, JI; Motoi, N; Nakajima, T; Nakatani, Y; Ota, M; Yoshino, I	1
de Carvalho Fraga, CA; de Souza, MG; Farias, LC; Guimarães, ALS; Guimarães, TA; Jones, KM; Xavier, GM	1
Celik, B; Demirag, MK; Elmali, M; Gulel, O	1
Akiba, J; Azuma, K; Hoshino, T; Ishii, H; Masuda, K; Matsuo, N; Naito, Y; Sakazaki, Y; Tokito, T; Tsuneyoshi, S; Yamada, K; Zaizen, Y	1
Ben Mrad, M; Chauleur, C; de Laroche, G; Espenel, S; Garcia, MA; Guy, JB; Langrand-Escure, J; Magné, N; Moreno-Acosta, P; Rancoule, C; Trone, JC; Vallard, A	1
Bardet, E; Bompas, E; Bourhis, J; Daly-Schveitzer, N; Lusinchi, A; Rolland, F; Rosine, D; Tao, Y	1
Brasch, F; Gehl, HB; Görner, M; Hirnle, P; Scholtz, LU; Sudhoff, H; Wegehenkel, K	1
Lee, DW; Lee, HN; Lee, JW; Lee, KH; Park, JS; Park, ST	1
Jamil, K; Naidu Madireddy, UR; Natukula, K; Pingali, UR; Suresh Attili, VS	1
Costello, BA; Dronca, RS; French, CA; Hilton, J; Marks, RS; Molina, JR; Nerby, CL; Parikh, SA; Peddareddigari, VG; Roden, AC; Shapiro, GI	1
Ichi, T; Ishikawa, K; Kawabata, T; Kawasaki, H; Taira, N; Yohena, T	1
Batus, M; Bonomi, P; Dandekar, VK; Fidler, MJ; Kiel, K; Sher, DJ; Young, J	1
Asamura, H; Fujiwara, Y; Horinouchi, H; Kanda, S; Kitazono, S; Mizugaki, H; Nokihara, H; Tamura, T; Tanaka, A; Tsuta, K; Yagishita, S; Yamamoto, N	1
Bigenzahn, J; Brunner, M; Heiduschka, G; Thurnher, D	1
Kadalayil, L; KhoshZaban, M; Kuku, S; Ledermann, J; Loddo, M; McCormack, M; Proctor, I	1
Du, XL; Li, HQ; Lu, CH; Pan, CX; Sheng, XG; Wang, C; Yin, YJ	1
Saleh, EM	1
Hassan, U; Mozayani, B; Wong, NA	1
Bonventre, JV; Ichimura, T; Ikemi, Y; Kim, YH; Masuda, S; Matsubara, K; Mishima, M; Ozawa, A; Sato, T; Shinke, H; Togashi, Y	1
Chen, H; Ding, F; Huang, F; Li, S; Li, Y; Liu, Z; Luo, A; Zhang, W; Zhao, Y	1
Bokhyan, V; Davydov, M; Fedyanin, M; Kononets, P; Malikhova, O; Minin, K; Pokataev, I; Shogenov, M; Stilidi, I; Tjulandin, S; Tryakin, A; Vybarava, A	1
Becker, M; Fichtner, I; Hammer, S; Hoffmann, J; Merk, J; Rolff, J; Sommer, A; Soong, R	1
Nagai, T; Okubo, T; Sakaguchi, R; Seki, H; Takeda, S	1
Coosemans, W; De Leyn, P; Decaluwé, H; Decker, G; Lerut, T; Lievens, Y; Moons, J; Nafteux, P; Van Raemdonck, D; Vansteenkiste, J	1
Drew, PA; Jamieson, GG; Liu, JF; Wu, TC; Zhu, GJ	1
Bao, QL; Chen, P; Dai, CH; Li, J; Li, XQ	1
Lv, L; Song, B; Song, X; Wang, X; Wei, L; Xie, L; Yu, J	1
Dimitrova, DD; Glanzer, JG; Manthey, KC; Oakley, GG	1
Baldi, A; Beleford, D; Boccellino, M; Liu, Z; Maguire, J; Molina, J; Quagliuolo, L; Rattan, R; Shridhar, V; Staub, J	1
Feigenberg, S; Huang, CH; Jotte, RM; Langer, CJ; Monberg, MJ; Movsas, B; Obasaju, CK; Ross, HJ; Wang, L; Xu, F	1
Chang, I; Chen, Z; Kang, M; Song, J; Wang, CY	1
Hiroshima, K; Kawamura, K; Kobayashi, H; Li, Q; Liang, M; Ma, G; Okamoto, S; Shimada, H; Suzuki, N; Tada, Y; Tagawa, M; Tatsumi, K	1
Abbruzzese, A; Addeo, R; Caraglia, M; Carbone, SF; Correale, P; Francini, G; Gotti, G; Licchetta, A; Martellucci, I; Migali, C; Remondo, C; Ricci, V; Rotundo, MS; Sperlongano, P; Tagliaferri, P; Tassone, P; Volterrani, L	1
Gupta, A; Mittal, B; Natu, SM; Negi, MP; Prasad, R; Srivastava, AN; Srivastava, S	1
Chang, PM; Chang, SY; Chen, MH; Chu, PY; Huang, YC; Tzeng, CH; Yang, MH	1
Lee, DW; Lee, HN; Lee, KH; Lee, YS; Park, EK; Park, JS	1
Cegovnik, U; Kern, I; Korošec, P; Košnik, M; Rijavec, M; Silar, M; Triller, N	1
Abbruzzese, A; Addeo, R; Apollinari, S; Basile, A; Bestoso, E; Botta, C; Caraglia, M; Correale, P; Gotti, G; Lamberti, M; Licchetta, A; Luzzi, L; Martellucci, I; Misso, G; Pagliuchi, M; Romano, O; Rotundo, MS; Tagliaferri, P	1
Boonstra, JJ; Dinjens, WN; Kok, TC; Siersema, PD; Ten Kate, FJ; Tilanus, HW; van Berge Henegouwen, MI; van der Gaast, A; van Heijl, M; van Lanschot, JJ; Wijnhoven, BP	1
Cho, JH; Cho, YJ; Kim, GC; Kim, S; Lee, MH; Park, BS	1
Ikeda, MA; Liu, J; Tsuchida, N; Uematsu, H	1
Chen, MC; Lee, KH; Li, TK; Pan, SL; Shi, Q; Teng, CM; Xiao, Z	1
Chen, CP; Jablons, DM; Jahan, TM; Weinberg, VK; Yom, SS	1
Chang, TC; Chen, CH; Chen, RJ; Chou, CH; Sheu, BC	1
Bouvy, JJ; Braun, JJ; Ruit, JB	1
Borca, VC; Cante, D; Canzi, P; Carassai, P; Catuzzo, P; Ceroni, P; Franco, P; Girelli, G; La Porta, MR; Migliaccio, F; Numico, G; Ozzello, F; Pasquino, M; Ricardi, U; Sciacero, P; Tofani, S	1
Iyoda, A; Jiang, SX; Kageyama, T; Masuda, N; Matsumoto, T; Nagashio, R; Ryuge, S; Saegusa, M; Sato, Y; Satoh, Y	1
Behrens, C; Correa, AM; Erasmus, JJ; Kalhor, N; Kim, ES; Lee, JJ; Pataer, A; Raso, MG; Roth, JA; Stewart, DJ; Swisher, SG; Vaporciyan, AA; Wistuba, II	1
Comans, EF; Hartemink, KJ; Paul, MA; Phernambucq, EC; Postmus, PE; Senan, S; Smit, EF	1
Bian, ML; Higuma, C; Isaka, K; Ito, H; Liang, J; Nishi, H; Sasaki, T	1
Bonner, JA; Geyer, SM; Goetz, SP; Jett, JR; Kugler, JW; Kuross, SA; Mailliard, JA; Marks, RS; McGinnis, WL; Schaefer, PL; Schild, SE; Stella, PJ	1
Abiko, M; Satoh, T	1
Boldt, S; Kolch, W; Weidle, UH	1
Bolton, M; Copur, S; Frankforter, S; Fruehling, RM; Ledakis, P; Mleczko, KL; Muhvic, J; Norvell, M; Novinski, D; VanWie, E	1
Itoh, M; Mizuguchi, J; Noutomi, T; Toyota, H	1
Miyamoto, T; Mukai, S; Nakagawa, T; Ryomoto, M; Tanaka, H; Yamamura, M; Yao, H; Yoshioka, Y	1
Dou, QP; Kuhn, DJ; Pross, S; Smith, DM; Whiteside, TL	1
Mimura, F; Okada, M; Sugihara, R; Tsurusaki, M	1
Antoch, G; Debatin, JF; Gutzeit, A	1
Burholt, DR; Donovan, M; George, LD; Kornblith, PL; Marsh, JW	1
Richter, P; Solecki, R; Szura, M; Zajac, A	1
Al-Hassani, M; Darst, M; Lewis, DA; Li, T; Travers, JB; Travers, JM; Yi, Q	1
Linghu, H; Mei, YY; Sun, T; Tang, JY; Tang, LD; Xu, XR	1
Dwarakanath, BS; Khaitan, D; Ravindranath, T	1
Albregts, M; Crezee, H; Fockens, P; González González, D; Hulshof, MC; Richel, DJ; van Dijk, JD; van Lanschot, JJ; Zum Vörde Sive Vörding, PJ	1
Achiwa, H; Bessho, Y; Hattori, N; Kato, D; Maeda, H; Niimi, T; Oguri, T; Sato, S; Shimizu, S; Ueda, R	1
Budach, W; Franke, C; Klump, B; Lehmann, N; Meyer, HJ; Schmitt, G; Schmitt, M; Seeber, S; Stahl, M; Stuschke, M; Teichmann, R; Walz, MK; Wilke, H	1
Lo Muzio, L; Mariggiò, A; Sen, S; Sharma, H; Singh, N	1
Chak, K; Chan, AT; Lam, KC; Lee, C; Mok, TS; Wong, H; Yeo, W; Yim, AP; Zee, B; Zhang, L	1
Endou, K; Kaira, K; Kamiyoshihara, M; Mori, M; Takise, A; Watanabe, R	1
Adam, AP; Aguirre-Ghiso, JA; Ranganathan, AC; Zhang, L	1
Cho, EK; Heo, DS; Jung, KH; Kim, JH; Kim, SY; Kim, YH; Lim, HY; Park, BJ; Park, K; Ryoo, BY; Suh, CW	1
Bai, T; Tanaka, T; Umesaki, N; Yukawa, K	1
Arvind, R; Kaneda, Y; Matsumura, K; Omura, K; Sakai, E; Shimamoto, H; Tsuchida, N; Zhang, S	1
Kawashima, O; Morishita, Y; Nagashima, T; Sugano, M	1
Atarashi, Y; Sato, TA; Stanson, J; Whiteside, TL; Wieckowski, E	1
Kamoto, T; Kawahara, T; Nishiyama, H; Ogawa, O; Yamamoto, S	1
Cai, Y; Wang, WL; Xu, B; Zhang, SW; Zhu, GY	1
Hashimoto, T; Izumi, Y; Kato, T; Kawada, K; Miura, A; Momma, K; Oota, M	1
Bourguignon, LY; Peyrollier, K; Wang, SJ	1
Feng, YL; Li, JD; Li, MD; Liu, JH; Shi, HL; Xiao, Y	1
Gotoh, M; Katsu, K; Kawabe, S; Kii, T; Kuwakado, S; Nishitani, H; Ohta, S; Takiuchi, H; Tanaka, T	1
Albain, KS; Chansky, K; Crowley, JJ; Gandara, DR; Gaspar, LE; Jett, J; Kelly, K; Lau, DH; Ung, YC	1
Alberto, P; Barrelet, L; Cavalli, F; Goldhirsch, A; Holdener, EE; Joss, RA; Mermillod, B; Obrecht, JP; Siegenthaler, P	1
Lamanna, S; Lopes-Pegna, A; Marino, C; Mazzei, T; Nozzoli, F; Periti, P; Righi, R; Santomaggio, C	1
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Sonntag, RW	1
Bitran, JD; Golomb, HM; Hoffman, PC	1
Hansen, HH; Pedersen, AG	1
Blum, RH; Foreman, JD; Muggia, FM	1
Berdel, WE; Diehl, V; Graubner, M; Gropp, C; Klippstein, T; Mende, S; Mitrou, PS	1
Creech, RH; Day, R; Ruckdeschel, JC; Stolbach, LL; Weissman, CH	1
Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R	1
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Mermillod, B	1
Blessing, JA; Homesley, HD; Slayton, RE	1
Berdel, WE; Diehl, V; Graubner, M; Gropp, C; Klippstein, TH; Mende, S; Mitrou, PS	1
Booser, DJ; Carr, DT; Chiuten, DF; Dhingra, HM; Farha, P; Issell, BF; Murphy, WK; Spitzer, G; Umsawasdi, T; Valdivieso, M	1
Bellamy, AS; Hill, BT	1
Aisner, J; Fuks, JZ; Levitt, M; Ostrow, S; Schipper, H; Van Echo, DA; Wiernik, PH	1
Bains, M; Coonley, CJ; Dukeman, M; Heelan, R; Kelsen, DP	1
Klastersky, J; Longeval, E	1
Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M	1
Casper, ES; Chapman, RA; Golbey, RB; Gralla, RJ; Itri, LM; Kelsen, DP	1
Creagan, ET; Eagan, RT; Kvols, LK	1
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, R; Kaplan, S; Obrecht, JP; Sonntag, R; Weber, W	1
Charrot-Chinet, P; Chauvergne, J; Héron, JF; Mayer, F; Toulouse, C	1
Ho, ES; Hsu, WP; Jan, JS; Lin, JC; Yang, CH	1
Hayakawa, O; Kudo, R; Takehara, M	1
Kok, T; Nooter, K; Smits, HL; ter Schegget, J; Tjong-A-Hung, SP	1
Hoshino, K; Mitsuya, T; Morioka, M; Noguchi, Y; Notake, Y; Okuyama, D; Shimizu, A; Takahashi, J; Watanabe, S; Yoda, A	1
Hosomura, Y; Izumi, M; Joshita, T; Kawashima, Y; Kobayashi, I; Lino, Y; Morishita, Y; Nakamura, S; Ogawa, T; Ohwada, S	1
Klinke, F; Micke, O; Rübe, C; von Eiff, M; Wagner, W; Willich, N	1
Ichikawa, G; Inuyama, Y; Kawaida, M; Kohno, N; Ohnuma, T; Shirasaka, T	1
Ichikawa, G; Kohno, N; Kusunoki, M; Nakazawa, E; Nishiya, M	1
Biller, H; Fujii, M; Holland, JF; Ohnuma, T; Okabe, M; Szrajer, L	1
Igawa, M; Kadena, H; Nakamoto, T; Tacho, T; Usui, T	1
Holden, SA; Northey, D; Robinson, MF; Rosowsky, A; Teicher, BA	1
Bassukas, ID; Hofmockel, G; Maurer-Schultze, B	1
Kobayashi, H; Obata, K	1
Hordijk, ML; Kok, TC; Mulder, AH; Wilson, JH	1
Kim, HJ; Kim, HK; Kim, SJ; Lee, DY; Paik, HC	1
Achterrath, W; Berger, M; Berns, T; Fink, U; Harstrick, A; Knipp, H; Meyer, HJ; Preusser, P; Stahl, M; Wilke, H	1
Hirabayashi, M; Kuno, K; Nakagawa, M; Tanaka, Y; Yoshida, H	1
Adkins, RB; Hoff, SJ; Johnson, DH; Merrill, WH; Murray, MJ; Sawyers, JL; Stewart, JR	1
Ando, M; Araki, N; Ikuta, N; Matsumoto, K; Suzuki, R; Takagi, K; Taki, F	1
Azzarello, G; Bari, M; Pappagallo, GL; Rosetti, F; Sampognaro, E; Segati, R; Vinante, O	1
Gemba, K; Kiura, K; Matsumura, T; Moritaka, T; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Takigawa, N; Ueoka, H	1
Mori, K; Suga, Y; Takahashi, T; Tominaga, K	1
Burgess, R; Dawson, D; Haller, J	1
Akagi, S; Kawakami, T; Koide, I; Masuda, Y; Ogawa, A; Ogawara, T; Takiguchi, S; Tamura, S; Watanabe, S	1
Imoto, M; Kakusui, M; Kashima, K; Misawa, S; Takashima, T; Taniwaki, M	1
Auerbach, M; Essig, L; Fryer, D; Fryer, J; Lokich, J	1
Akimoto, K; Akimoto, S; Kasahara, T; Kato, M; Kinoshita, M; Kizu, O; Komatsu, T; Maeda, T; Minami, K; Nakaoka, Y; Sekikawa, S; Shimizu, T	1
Fang, Y; Song, M; Wang, G; Xu, H	1
Göbel, U; Harms, D; Jürgens, H; Niehues, T	1
Breuer, N; Eigler, FW; Fett, W; Fink, U; Makoski, HB; Molls, M; Niebel, W; Sack, H; Schmidt, U; Seeber, S; Siewert, JR; Stahl, M; Stuschke, M; Walz, MK; Wilke, H	1
Ho, ES; Jan, JS; Lin, JC; Liu, FS; Yang, CH	1
Brewer, Y; Chauvet, B; Faure, CF; Reboul, F; Taulelle, M; Vincent, P	1
Allen, GC; Devore, RF; Lubas, S; Wax, MK	1
Hashimoto, H; Iuchi, H; Morikawa, M; Numata, A; Tokumitsu, M; Yachiku, S; Yamauchi, K	1
Shen, H; Xiong, W	1
Anderson, N; Bern, M; Coco, F; Dow, E; Lokich, J; Moore, C	1
Fukabori, T; Mizobuchi, K; Nakamura, M; Yokomura, I	1
Hayasaka, S; Kinuwaki, E; Komatsu, H; Nakabayashi, T; Nakai, Y; Niitani, H; Nishikawa, H; Ohizumi, K; Saito, R; Shimizu, T	1
Bolzicco, G; Crinó, L; De Marinis, F; Emiliani, E; Figoli, F; Gentile, A; Marangolo, M; Maranzano, E; Masiero, P; Meacci, L; Morandi, MG; Ricardi, U; Rosti, G; Scagliotti, GV; Tonato, M	1
Hejna, M; Kornek, GV; Raderer, M; Rosen, H; Scheithauer, W; Schiessel, R; Schoder, M; Schratter-Sehn, AU; Zach, M	1
Clynes, M; Coyle, S; Daly, C; Daly, N; McBride, S; O'Driscoll, L; Scanlon, K	1
Clynes, M; Dolan, E; Heenan, M; Kavanagh, K; Maher, M; Moriarty, M; O'Neill, P; Redmond, A	1
Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T	1
Arwidi, A; Brink, J; Brodin, O; Lindén, CJ; Lundström, R; Mercke, C; Nou, E; Ringborg, U	1
Belli, M; Bianco, A; Cioffi, R; Comella, G; Comella, P; Curcio, C; De Cataldis, G; Della Vittoria, M; Frasci, G; Ianniello, G; Maiorino, L; Panza, N; Perchard, J	1
Abe, S; Fujita, A; Hayashi, I; Kawakami, Y; Kurita, Y; Matsuda, T; Nakabayashi, T; Nishiwaki, Y; Noda, K; Oshita, F; Saijo, N; Suzuki, S; Takahashi, S; Tamura, T; Tobise, K; Tsuchiya, S	1
Betsuyaku, T; Hanada, T; Hasegawa, A; Hizawa, N; Isobe, H; Kawakami, Y; Ogura, S; Yamazaki, K	1
Zukowska, H; Zwoliński, J	1
Inoda, H; Kutsuki, M; Mori, M; Nishikawa, M; Nishimura, K; Takigami, K; Yamaguchi, Y; Yamamoto, C; Yoshitake, K	1
Heilmann, HP	1
Irwin, JF; Poussin-Rosillo, H; Sardi, A; Waterfield, W	1
Radzikowska, E; Rowińska-Zakrzewska, E; Sakowicz, A; Załeska, J; Zych, J	1
Kasai, H; Maekawa, R; Sugita, K; Takeda, Y; Uchida, N; Yoshioka, T	1
Bishop, JF; Millward, MJ; Quinn, M; Rischin, D; Rome, R; Tebbutt, N; Toner, GC	1
Chang, L; Ogita, S; Tanaka, T; Umesaki, N	1
Beppu, M; Chiba, T; Hiura, M; Kawakami, Y; Nogawa, T; Yokoyama, T	1
Bosman, FT; Kok, T; Nooter, K; Stoter, G; van Wingerden, KE	1
Obłakowski, P; Radzikowska, E; Rowińska-Zakrzewska, E; Słodkowska, J; Załeska, J; Zych, J	1
Müller, C; Stahl, M; Stuschke, M; Vanhoefer, U; Walz, MK; Wilke, H	1
Blessing, JA; Rose, PG; Van Le, L; Waggoner, S	1
Hatae, M; Hiura, M; Hoshiai, H; Ikeda, M; Izumi, R; Noda, K; Ogita, Y; Okada, H; Ozaki, M; Ozawa, M; Tamaya, T; Tanaka, K; Yamabe, T	1
Craffey, M; Dowlati, A; Levitan, N; MacKay, W; McKenney, J; Remick, SC; Tahsildar, H	1
Chao, HT; Chiang, H; Lai, CR; Lee, SD; Lee, WL; Ng, HT; Tseng, JY; Wang, PH; Yuan, CC	1
Barrows, LR; Haughey, HM; Holden, JA; Ireland, CM; Matsumoto, SS; Schmehl, DM; Venables, DA	1
Hirano, K; Honma, T; Mino, K; Nakabayashi, T; Saitoh, H; Takada, M; Takeda, T; Wada, I; Yokouchi, M	1
Ekimoto, H; Mashiba, H; Matsumoto, S; Okamoto, K	1
Hada, T; Kobayashi, I; Kohno, S; Matai, K; Oda, Y; Ohmori, H; Sasaya, K; Yamazaki, Y	1
Abe, T; Hayashi, H; Hazama, S; Hirose, K; Iizuka, N; Noma, T; Oka, M; Tangoku, A; Yamamoto, K	1
Andras, E; Byhardt, R; Cox, J; Dar, AR; Johnson, D; Komaki, R; Lawton, C; Lee, JS; Movsas, B; Roach, M; Sause, W; Scott, C; Wasserman, T	1
Bereiter-Hahn, J; Cervinka, M; Cervinková, Z; Peychl, J; Rudolf, E	1
Andras, EJ; Byhardt, RW; Graham, ML; Roach, M; Scott, C; Smith, C; Werner-Wasik, M	1
Arimoto, J; Bessho, T; Furukawa, T; Hirai, I; Maebeya, S; Matsuyama, K; Naito, Y; Oura, S; Sakurai, T; Suzuma, T; Tanino, H; Yano, T; Yoshimasu, T	1
Oldenburg, A; Sack, H; Seeber, S; Stahl, M; Stüben, G; Stuschke, M; Walz, M; Wilke, H	1
Imaizumi, M; Seki, Y; Takeuchi, M; Yamada, K; Yoshioka, H	1
Ikari, T; Kano, S; Kawaida, M; Kawaura, M; Kohno, N; Nakamizo, M; Tanaka, K	1
Arai, T; Hayakawa, K; Kashiki, Y; Shibayama, M; Shibuya, C; Takaya, T; Toshima, S; Yasuda, Y; Yoshimi, N	1
Koshiishi, H; Takahashi, E; Tamamoto, F; Utsumi, K	1
Catalano, G; De Cataldis, G; De Vita, F; Galizia, G; Infusino, S; Lieto, E; Orditura, M; Romano, C	1
Amo-Takyi, BK; Boabang, P; Kohlhagen, H; Kurbacher, CM; Waida, A	1
Fujishiro, M; Fukuda, H; Fukuda, M; Kunitoh, H; Nishiwaki, Y; Ohe, Y; Saijo, N; Sekine, I; Shinkai, T; Tamura, T	1
Gastman, BR; Johnson, DE; Rabinowich, H; Wang, GQ; Watkins, SC; Wieckowski, E; Yin, XM	1
Kok, TC; Polee, MB; Siersema, PD; Splinter, TA; Stoter, G; Tilanus, HW; Van der Gaast, A	1
Fujita, S; Hasegawa, T; Ikeda, A; Kaneshiro, E; Katakami, N; Nishimura, T; Nishio, C; Okazaki, M; Umeda, B	1
Glicksman, AS; Liu, L; Weitberg, AB; Yashar, J	1
Clarke, P; Geraci, MW; Johnson, GL; Jotte, RM; Scheinman, RI; Spalding, AC; Tyler, KL	1
Bonnette, P	1
Adamson, RH; Mead, JA; Sieber, SM	1
Creagan, ET; Eagan, RT; Frytak, S; Ingle, JN; Kvols, LK; McMachon, RT; Rubin, J	1
Brunner, KW; Cavalli, F; Hasler, E; Martin, J; Ryssel, HJ; Sonntag, RW; Tschopp, L	1
Fujita, J; Fujita, T; Irino, S; Kubo, A; Morikawa, N; Shiotani, T; Takahara, J; Takigawa, K; Yamagishi, Y; Yamaji, Y	1
Alftan, H; Lehtovirta, P; Leminen, A; Stenman, UH	1
Dhingra, HH; Greenberg, J; Hong, WK; Lee, JS; Shirinian, M	1
Hikita, M; Kobayashi, M; Kohno, K; Saito, T; Sato, S; Takano, H	1
Furukawa, S; Inoue, T; Ito, K; Kokatsu, T; Mochimatsu, I; Sawaki, S; Tsukuda, M; Watanabe, S	1
Band, PR; Connors, JM; Fetherstonhaugh, EM; Goldie, JH; Knowling, MA; Osoba, D	1
Roth, JA	1
Chapuis, JC; Keng, PC; Siemann, DW	2
Akiyama, M; Inoue, Y; Sumiyoshi, Y; Yokota, K	1
Bokemeyer, C; Harstrick, A; Knipp, H; Köhne-Wömpner, CH; Meyer, HJ; Preusser, P; Schmoll, HJ; Stahl, M; Wilke, H	1
Kohno, K; Kuwano, M; Ono, M; Takano, H; Uchida, Y	1
Levine, PA; Tabbara, IA	1
Aoki, Y; Hiura, K; Katoh, O; Kuroki, S; Yamada, H	1
Hirai, M	1
Coninx, P; Desoize, B; Legros, M; Woirin, V	1
Karsai, H; Little, C; Murray, N; Osoba, D; Page, R; Shah, A	1
Bonomi, P; Gale, M; Kittle, CF; Lee, MS; Phillips, A; Purl, S; Reddy, S; Rowland, K; Taylor, SG; Warren, W	1
Bungo, M; Fujita, J; Futami, H; Hashimoto, Y; Hata, Y; Irino, S; Kamei, M; Nakamura, H; Shiotani, T; Yamaji, Y	1
Bitran, JD; Comis, RL; Ettinger, DS; Harris, CL; Harwood, KV; Keller, JH; Langer, CJ; Losada, M	1
Asamoto, H; Fujii, H; Kawaguchi, H; Kawakami, A; Ozawa, Y; Sawano, T; Tsutsumi, T	1
Abbruzzese, JL; Faintuch, J; Frost, P; Raber, MN; Sumrall, C	1
Canova, N; Casadio, M; Guaraldi, M; Lelli, G; Pannuti, F	1
Andreeff, M; Howell, SB; Shalinsky, DR	1
Ishii, S; Itoh, O; Kariya, Y; Kawaharajo, K; Nagasawa, M; Takeuchi, T; Yamamoto, H	1
Bureau, G; Cordier, R; Dabouis, G; Klastersky, J; Lecomte, J; Libert, P; Ravez, P; Sculier, JP; Thiriaux, J; Vandermoten, G	2
Achterrath, W; Gatzemeier, U; Heckmayr, M; Hossfeld, D; Lenaz, L; Neuhauss, R	1
Brandes, A; Cipriani, A; Favaretto, A; Festi, G; Fornasiero, A; Ghiotto, C; Paccagnella, A; Pappagallo, G; Vinante, O; Volpi, A	1
Beauduin, M; Bosly, A; Duprez, P; Humblet, Y; Majois, F; Prignot, J; Schallier, D; Symann, M; Weynants, P	1
Gradishar, WJ; Kies, MS; Vokes, EE	1
Coninx, P; Legros, M; Nguyen, TD; Panis, X	1
Adachi, S; Hirooka, C; Ichijo, M; Kiyozuka, Y; Noda, T; Oku, M; Yamamoto, T	1
Evans, WK; Osoba, D; Rusthoven, JJ; Shepherd, FA; Turnbull, KA	1
Ito, M	1
Chan, D; Glisson, BS; Hong, WK; Kim, HK; Sacks, PG; Silberman, L; Zwelling, LA	1
Braun, ID; Kennedy, KA; Lazo, JS; Meandzija, B; Pham, ET; Smaldone, LF	1
Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Stieber, P	1
Carlson, LS; Osguthorpe, JD; Stuart, R	1
Ardizzoni, A; Baracco, F; Capaccio, A; Fabiano, F; Felletti, R; Fusco, V; Gulisano, M; Nosenzo, M; Pastorino, G; Pronzato, P	1
Bonomi, P; Faber, LP; Hendrickson, FR; Kittle, CF; Lee, MS; Pincus, M; Reddy, S; Rowland, K; Taylor, S; Warren, W	1
Creagan, ET; Kovach, JS; Richardson, RL	1
Becker, H; Bülzebruck, H; Djawid, N; Drings, P; Ruchalla, E; Stiefel, P; Tessen, HW	1
Brust, J; Paschke, R; Queisser, W; Worst, P	1
Carr, DT; Chiuten, DF; Dhingra, HM; Farha, P; Murphy, WK; Spitzer, G; Umsawasdi, T; Valdivieso, M	1
Drings, P; Manke, HG	1
Chikata, E; Hara, K; Ito, F; Kado, M; Kanda, T; Matsui, Y; Nakayama, M; Ohshima, S; Sakai, S; Shimokata, K	1
Kimura, K; Niitani, H	1
Hara, K; Kado, M; Kanda, T; Matsui, Y; Oshima, S; Shima, K; Shimokata, K; Takenaka, S	1
Fukuda, Y; Homma, T; Nakata, M; Noguchi, Y; Yoneda, S; Yoshida, S	1
Colozza, MA; Crinò, L; Davis, S; Grignani, F; Lubansky, K; Tonato, M	1
Abel, U; Bülzebruck, H; Drings, P; Kleckow, M; Manke, HG; Stiefel, P	1
Gallurt Moreira, P; Millan Nuñez-Cortes, J; Senra Varela, A	1
Löhr, G; Musil, J; Nagel, GA; Rauschning, W; Schröder, M; Schuff-Werner, P	1
Barreras, L; Manten, H; Saldana, MJ; Sridhar, KS	1
Shiu, WC; Tsao, SY	1
Roseman, JM	1
Beecham, J; Blessing, JA; DiSaia, PJ; Slayton, RE	1
Holthuis, JJ; Hulshoff, B; Mulder, NH; Postmus, PE; Sleijfer, DT; Van Oort, WJ; Verleun, H	1
Bertetto, O; Calciati, A; Clerico, M; Dongiovanni, V	1
Ettinger, DS; Finkelstein, DM; Ruckdeschel, JC	1
Barnadas, A; Izquierdo, A; Lopez Lopez, JJ; Pallares, C; Piera, JM	1
Ardizzoni, A; Baracco, F; Canobbio, L; De Palma, M; Faravelli, B; Nosenzo, M; Pronzato, P; Rubagotti, A; Serrano, J; Serrano, S	1
Canobbio, L; Fassio, T; Gasparini, G; Villani, F	1
Kubo, H; Maeda, T; Okamura, S; Sano, T; Sugimoto, O; Ueda, M; Ueki, M; Yamada, T	1
Applebaum, EL; Cobleigh, MA; Hill, JH; Lad, TE; Shevrin, DE	1
Christensen, IJ; Hansen, HH; Roed, H; Spang-Thomsen, M; Vindelov, LL	1
Anderson, G; Payne, H	1
Birch, R; Enas, G; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Porter, LL; Wolff, SN	1
Chetiyawaraana, AD; Cullen, MH; Latief, TN; Mould, JJ; Spooner, D	1
Felman, IE; Gala, KV; Grunberg, SM; Johnson, KB; Owens, JC	1

Reviews

10 review(s) available for etoposide and Carcinoma, Squamous Cell

Article	Year
Pathways Related to the Anti-Cancer Effects of Metabolites Derived from Cerrado Biome Native Plants: An Update and Bioinformatics Analysis on Oral Squamous Cell Carcinoma. Protein and peptide letters, 2021, Volume: 28, Issue:7 Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Brazil; Carcinogenesis; Carcinoma, Squamous Cell; Cell Proliferation; Computational Biology; Etoposide; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Mouth Neoplasms; Neoplasm Proteins; Paclitaxel; Plant Extracts; Plants, Medicinal; Vinblastine	2021
Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Seminars in oncology, 1983, Volume: 10, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Prognosis; Vinblastine; Vindesine	1983
Etoposide (VP-16) in the treatment of lung cancer. Cancer treatment reviews, 1983, Volume: 10, Issue:4 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Time Factors	1983
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies. International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Mitoguazone; Vinblastine; Vindesine	1984
New agents in non-small cell lung cancer. Cancer treatment reviews, 1984, Volume: 11, Issue:3 Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine	1984
Surgical treatment of stage III lung cancer after chemotherapy and radiotherapy. Japanese journal of clinical oncology, 1994, Volume: 24, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fluorouracil; Follow-Up Studies; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Radiotherapy Dosage; Remission Induction	1994
Treatment of pediatric malignant thymoma: long-term remission in a 14-year-old boy with EBV-associated thymic carcinoma by aggressive, combined modality treatment. Medical and pediatric oncology, 1996, Volume: 26, Issue:6 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Ifosfamide; In Situ Hybridization; Male; Radiotherapy Dosage; Remission Induction; RNA, Viral; Thymectomy; Thymoma; Thymus Neoplasms; Treatment Outcome; Tumor Virus Infections	1996
[An elderly case of squamous cell lung cancer showing partial response by daily administration of oral etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:9 Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male	1996
[Lymph node excision in the surgical treatment of bronchopulmonary cancer]. Revue de pneumologie clinique, 2001, Volume: 57, Issue:5 Pt 2 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Axilla; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Lymph Node Excision; Postoperative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors	2001
Pharmacology of antitumor agents from higher plants. Cancer treatment reports, 1976, Volume: 60, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Aporphines; Camptothecin; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Etoposide; Humans; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Maytansine; Melanoma; Naphthoquinones; Nasopharyngeal Neoplasms; Neoplasms; Neoplasms, Experimental; Phenanthrenes; Structure-Activity Relationship; Teniposide; Vinblastine; Vincristine	1976

Trials

69 trial(s) available for etoposide and Carcinoma, Squamous Cell

Article	Year
Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004-02. Radiation oncology (London, England), 2013, Feb-27, Volume: 8 Topics: Administration, Oral; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Chemoradiotherapy; Dose Fractionation, Radiation; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis	2013
Do Cell-Cycle Phase-Specific Markers Predict Disease Grade, Stage, and Outcome in Cervical Carcinoma? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Cell Cycle; Chemoradiotherapy; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Young Adult	2015
Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5 Topics: Acute Kidney Injury; Acute-Phase Proteins; Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; beta 2-Microglobulin; Biomarkers; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chemokine CCL2; Cisplatin; Creatinine; Etoposide; Female; Hepatitis A Virus Cellular Receptor 1; Humans; Lipocalin-2; Lipocalins; Lung Neoplasms; Male; Membrane Glycoproteins; Middle Aged; Neoplasm Proteins; Proto-Oncogene Proteins; Receptors, Virus; ROC Curve; Vinblastine; Vinorelbine	2015
Preoperative chemotherapy in patients with resectable esophageal carcinoma: a single center Phase II study. Japanese journal of clinical oncology, 2016, Volume: 46, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies	2016
A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia. Annals of surgical oncology, 2009, Volume: 16, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Carcinoma, Squamous Cell; Cardia; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclooxygenase 2 Inhibitors; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Stomach Neoplasms; Survival Analysis	2009
Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010, Volume: 5, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Etoposide; Feasibility Studies; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Taxoids; Treatment Outcome	2010
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients. Cancer biology & therapy, 2010, May-01, Volume: 9, Issue:9 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Angiopoietin-1; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Prospective Studies; Survival Rate; Thrombospondins; Treatment Outcome; Vascular Endothelial Growth Factor A	2010
A study using ifosfamide and etoposide in patients with cisplatin-refractory recurrent or metastatic head and neck squamous cell carcinoma. Japanese journal of clinical oncology, 2011, Volume: 41, Issue:5 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Research Design; Risk Factors; Taiwan; Treatment Outcome	2011
Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Hysterectomy; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Survival Rate; Uterine Cervical Neoplasms	2011
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients. Cancer biology & therapy, 2011, Jul-15, Volume: 12, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging	2011
Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial. BMC cancer, 2011, May-19, Volume: 11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome	2011
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer. International journal of radiation oncology, biology, physics, 2002, Oct-01, Volume: 54, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Prospective Studies; Radiotherapy; Radiotherapy Dosage; Survival Analysis	2002
A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2004, Volume: 20, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Feasibility Studies; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Neoplasm Staging; Patient Selection; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome	2004
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-01, Volume: 23, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Survival Analysis	2005
Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer. Oncology, 2005, Volume: 68, Issue:4-6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Quality of Life; Survival Rate; Treatment Outcome	2005
Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience. Lung cancer (Amsterdam, Netherlands), 2006, Volume: 52, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Korea; Lung Neoplasms; Male; Middle Aged; Survival Rate; Treatment Outcome	2006
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, May-20, Volume: 26, Issue:15 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Etoposide; Female; Follow-Up Studies; Gefitinib; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Quinazolines; Remission Induction; Survival Rate; Taxoids	2008
Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide. Cancer treatment reports, 1984, Volume: 68, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins	1984
Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Seminars in oncology, 1983, Volume: 10, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Prognosis; Vinblastine; Vindesine	1983
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies. International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Mitoguazone; Vinblastine; Vindesine	1984
Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV). Cancer treatment reports, 1984, Volume: 68, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Vinblastine	1984
[Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study]. Onkologie, 1984, Volume: 7, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Vinblastine; Vindesine	1984
New agents in non-small cell lung cancer. Cancer treatment reviews, 1984, Volume: 11, Issue:3 Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine	1984
Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Random Allocation	1983
Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery. Japanese journal of clinical oncology, 1995, Volume: 25, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Male; Middle Aged; Peplomycin; Pilot Projects; Survival Rate; Thyroid Neoplasms; Thyroidectomy	1995
[Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide]. Bulletin du cancer, 1993, Volume: 80, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Mitomycins; Uterine Cervical Neoplasms	1993
Concomitant chemoradiotherapy for advanced epidermoid carcinoma of the uterine cervix: a preliminary report. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1994, Volume: 54, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Prospective Studies; Remission Induction; Uterine Cervical Neoplasms	1994
Neoadjuvant chemotherapy with etoposide, leucovorin, 5-fluorouracil and cisplatin for advanced esophageal squamous cell carcinoma. Japanese journal of clinical oncology, 1995, Volume: 25, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Pilot Projects; Survival Rate	1995
[Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1995, Volume: 171, Issue:7 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate; Vindesine	1995
Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22 Suppl 3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Mitomycin; Nausea; Salvage Therapy; Vomiting	1995
Preliminary results of methotrexate, etoposide and cisplatin in the treatment of urothelial cancer. Urologia internationalis, 1995, Volume: 54, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Remission Induction; Survival Rate; Urologic Neoplasms	1995
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	1994
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Remission Induction; Thrombocytopenia; Treatment Outcome	1994
The combination of mitomycin, vinblastine and cisplatin is active in the palliation of stage IIIB-IV non-small-cell lung cancer. Oncology, 1993, Volume: 50, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Staging; Quality of Life; Remission Induction; Vinblastine	1993
Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188. The Journal of infusional chemotherapy, 1995,Spring, Volume: 5, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate	1995
Prospective trial of combined hyperfractionated radiotherapy and bronchial arterial infusion of chemotherapy for locally advanced nonsmall cell lung cancer. International journal of radiation oncology, biology, physics, 1996, Jan-15, Volume: 34, Issue:2 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis	1996
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cause of Death; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Preoperative Care; Survival Analysis; Treatment Failure	1996
Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study. International journal of radiation oncology, biology, physics, 1996, May-01, Volume: 35, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis	1996
Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE). The Journal of infusional chemotherapy, 1996,Winter, Volume: 6, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia	1996
[Early phase II study of oral administration of etoposide for 21 consecutive days in patients with non-small-cell lung cancer]. Nihon Kyobu Shikkan Gakkai zasshi, 1995, Volume: 33, Issue:12 Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male	1995
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Recombinant Proteins; Survival Rate	1996
Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma. Cancer, 1996, Oct-15, Volume: 78, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis	1996
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine	1996
Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study Group. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Rate	1996
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano. British journal of cancer, 1996, Volume: 74, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cause of Death; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prognosis; Survival Analysis; Vinblastine; Vinorelbine	1996
Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged	1997
[CPE chemotherapy for tongue carcinoma--clinical effects and side effects]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:7 Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Nausea; Peplomycin; Tongue Neoplasms; Vomiting	1997
A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix. The Australian & New Zealand journal of obstetrics & gynaecology, 1998, Volume: 38, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Confidence Intervals; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Uterine Cervical Neoplasms	1998
Expression of the multidrug resistance protein (MRP) in squamous cell carcinoma of the oesophagus and response to pre-operative chemotherapy. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Esophageal Neoplasms; Etoposide; Female; Genes, MDR; Humans; Immunohistochemistry; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Preoperative Care; Prospective Studies; RNA, Messenger	1998
[Cytostatic treatment of patients with advanced non-small cell lung cancer]. Pneumonologia i alergologia polska, 1998, Volume: 66, Issue:1-2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Remission Induction; Survival Rate; Vinblastine	1998
Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecologic oncology, 1998, Volume: 70, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms	1998
[Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Nausea; Uterine Cervical Neoplasms; Vomiting	1998
A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial. Lung cancer (Amsterdam, Netherlands), 1998, Volume: 22, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite Stimulants; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Megestrol Acetate; Mesna; Middle Aged; Protective Agents; Recombinant Proteins; Survival Analysis; Treatment Outcome	1998
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. International journal of radiation oncology, biology, physics, 1999, Dec-01, Volume: 45, Issue:5 Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Humans; Karnofsky Performance Status; Lung Neoplasms; Middle Aged; Neoplasm Staging; Prospective Studies; Quality-Adjusted Life Years; Survival Analysis	1999
Survival results of neoadjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck. Japanese journal of clinical oncology, 2000, Volume: 30, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Survival Analysis	2000
[Evaluation of bronchial arterial infusion (BAI) for high risk lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:12 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Camptothecin; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intra-Arterial; Irinotecan; Lung Neoplasms; Male; Middle Aged	2000
Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408. Japanese journal of clinical oncology, 2000, Volume: 30, Issue:11 Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Irinotecan; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged	2000
Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus. Anti-cancer drugs, 2001, Volume: 12, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged	2001
[Squamous cell cancer of the esophagus. Treatment concept at the Houston M.D. Anderson Cancer Center]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1992, Volume: 63, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Neoplasm Staging; Prospective Studies; Texas	1992
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus. Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:4 Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Remission Induction; Time Factors	1992
Small-cell carcinoma of the head and neck. A novel treatment regimen. American journal of clinical oncology, 1991, Volume: 14, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Laryngeal Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radiotherapy Dosage; Remission Induction; Tongue Neoplasms; Vincristine	1991
Brief intensive chemotherapy for metastatic non-small-cell lung cancer: a phase II study of the weekly CODE regimen. Journal of the National Cancer Institute, 1991, Feb-06, Volume: 83, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prednisone; Remission Induction; Survival Rate; Vincristine	1991
Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin. Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Fluorouracil; Humans; Middle Aged; Neoplasms, Unknown Primary; Remission Induction; Survival Rate	1991
A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party. Seminars in oncology, 1990, Volume: 17, Issue:1 Suppl 2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Randomized Controlled Trials as Topic; Survival Rate	1990
Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm. Cancer, 1990, Jun-15, Volume: 65, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Randomized Controlled Trials as Topic; Remission Induction	1990
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Random Allocation	1989
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:2 Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Random Allocation; Vinblastine; Vindesine	1985
[Effect of thymostimulin on chemotherapy-induced changes in lymphocyte subset distribution. A longitudinal study in patients with primary inoperable oropharyngeal cancers]. Onkologie, 1987, Volume: 10, Issue:3 Suppl Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunotherapy; Longitudinal Studies; Lymphocytes; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Thymus Extracts	1987
Response rate and toxicity of etoposide (VP-16) in squamous carcinoma of the lung: report from the Lung Cancer Treatment Study Group. Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2 Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin	1985

Other Studies

196 other study(ies) available for etoposide and Carcinoma, Squamous Cell

Article	Year
New diarylheptanoids and diarylheptanoid glucosides from the rhizomes of Tacca chantrieri and their cytotoxic activity. Journal of natural products, 2002, Volume: 65, Issue:3 Topics: Antineoplastic Agents, Phytogenic; beta-Glucosidase; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Circular Dichroism; Diarylheptanoids; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Fibroblasts; Gingiva; Glucosides; Glycoside Hydrolases; Heptanes; Humans; Hydrolysis; Leukemia, Myeloid; Molecular Conformation; Molecular Structure; Multienzyme Complexes; Nuclear Magnetic Resonance, Biomolecular; Phenols; Plants, Medicinal; Rhizome; Tumor Cells, Cultured	2002
Bulbinelonesides A-E, phenylanthraquinone glycosides from the roots of Bulbinella floribunda. Journal of natural products, 2003, Volume: 66, Issue:6 Topics: Anthraquinones; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cells, Cultured; Circular Dichroism; Drug Screening Assays, Antitumor; Glycosides; Humans; Inhibitory Concentration 50; Japan; Liliaceae; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Plants, Medicinal; Stereoisomerism; Tumor Cells, Cultured	2003
Oleanane and taraxerane glycosides from the roots of Gomphrena macrocephala. Journal of natural products, 2006, Volume: 69, Issue:11 Topics: Amaranthaceae; Antineoplastic Agents, Phytogenic; Brazil; Carcinoma, Squamous Cell; Drug Screening Assays, Antitumor; Glucosides; Glycosides; Humans; Oleanolic Acid; Plant Roots; Plants, Medicinal; Structure-Activity Relationship; Triterpenes	2006
Ectopically Expressed Meiosis-Specific Cancer Testis Antigen HORMAD1 Promotes Genomic Instability in Squamous Cell Carcinomas. Cells, 2023, 06-14, Volume: 12, Issue:12 Topics: Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; DNA Damage; DNA Repair; Etoposide; Genomic Instability; Humans; Meiosis; Mitosis	2023
Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179. Clinical lung cancer, 2020, Volume: 21, Issue:3 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase II as Topic; Consolidation Chemotherapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Paclitaxel; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate	2020
Chemotherapy dosing and toxicity in a patient with muscular dystrophy. Cancer reports (Hoboken, N.J.), 2018, Volume: 1, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Muscular Dystrophies, Limb-Girdle; Myelopoiesis; Palliative Care	2018
Pulmonary microinvasive small cell carcinoma with an extensive in-situ component identified after photodynamic therapy for 'squamous cell carcinoma in situ': a case report. Histopathology, 2021, Volume: 78, Issue:6 Topics: Aged; Antineoplastic Agents; Bronchoscopy; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Humans; Lung Neoplasms; Male; Photochemotherapy; Small Cell Lung Carcinoma	2021
A rare complication of metastatic lung disease treatment. Saudi medical journal, 2017, Volume: 38, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Erlotinib Hydrochloride; Etoposide; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Pericardium; Tomography, X-Ray Computed; Tongue Neoplasms	2017
Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor. Internal medicine (Tokyo, Japan), 2018, Dec-01, Volume: 57, Issue:23 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinoma, Squamous Cell; Docetaxel; Etoposide; Humans; Immunohistochemistry; Lung Neoplasms; Male; Pleural Effusion, Malignant; Small Cell Lung Carcinoma	2018
Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years' experience. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2018, Volume: 22, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Iridium Radioisotopes; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies; Risk; Treatment Outcome; Uterine Cervical Neoplasms	2018
Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas--a single institution experience. European journal of cancer care, 2013, Volume: 22, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome	2013
Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2013, Volume: 23, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms	2013
Survival analysis in advanced non small cell lung cancer treated with platinum based chemotherapy in combination with paclitaxel, gemcitabine and etoposide. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate	2013
NUT midline carcinoma: an aggressive intrathoracic neoplasm. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Gene Rearrangement; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Male; Nuclear Proteins; Oncogene Proteins, Fusion; Prognosis; Thoracic Neoplasms; Translocation, Genetic	2013
Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2014, Volume: 40, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Thymectomy; Thymoma; Thymus Neoplasms; Treatment Outcome; Vincristine	2014
Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer. American journal of clinical oncology, 2015, Volume: 38, Issue:6 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Chest Pain; Cohort Studies; Cough; Dyspnea; Esophagitis; Etoposide; Female; Hemoptysis; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Palliative Care; Pemetrexed; Radiation Injuries; Radiation Pneumonitis; Retrospective Studies; Treatment Outcome	2015
Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases. Japanese journal of clinical oncology, 2014, Volume: 44, Issue:9 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome	2014
Resveratrol synergistically enhances the effect of etoposide in HNSCC cell lines. Acta oto-laryngologica, 2014, Volume: 134, Issue:10 Topics: Analysis of Variance; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Reference Values; Resveratrol; Squamous Cell Carcinoma of Head and Neck; Stilbenes	2014
The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pelvic Neoplasms; Prognosis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Remission Induction; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms	2015
Inhibition of topoisomerase IIα sensitizes FaDu cells to ionizing radiation by diminishing DNA repair. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:11 Topics: Antigens, Neoplasm; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Repair; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Humans; Pharyngeal Neoplasms; Radiation Tolerance; Radiation, Ionizing; Topoisomerase II Inhibitors	2015
Primary combined neuroendocrine carcinoma (small-cell type) and squamous cell carcinoma of the colon. Histopathology, 2016, Volume: 68, Issue:5 Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Colon; Colonic Neoplasms; Etoposide; Fatal Outcome; Humans; Male; Platinum; Point Mutation; Proto-Oncogene Proteins p21(ras); Tomography, X-Ray Computed	2016
Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner. The Journal of biological chemistry, 2016, Mar-25, Volume: 291, Issue:13 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Proliferation; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; Esophageal Neoplasms; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Protein 1; JNK Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-fos; RNA, Small Interfering; Signal Transduction; Survival Analysis; Transcription Factor AP-1	2016
Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Oct-15, Volume: 14, Issue:20 Topics: Adenocarcinoma; Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cetuximab; Deoxycytidine; Disease Models, Animal; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Etoposide; Female; Gemcitabine; Gene Expression Profiling; Genes, ras; Humans; Immunoblotting; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Middle Aged; Mutation; Oligonucleotide Array Sequence Analysis; Paclitaxel; Polymerase Chain Reaction; Prognosis; Protein Kinase Inhibitors; Quinazolines; Radiation-Sensitizing Agents; Small Cell Lung Carcinoma; Tumor Suppressor Protein p53; Vinblastine; Vinorelbine; Xenograft Model Antitumor Assays	2008
Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy. International journal of clinical oncology, 2008, Volume: 13, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Neoadjuvant Therapy; Neoplasm Staging; Treatment Outcome; Uterine Cervical Neoplasms	2008
Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Prognosis; Prospective Studies; Radiotherapy Dosage; Remission Induction; Survival Rate; Tomography, X-Ray Computed	2009
Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. Oncology, 2009, Volume: 76, Issue:5 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Deoxycytidine; Disease Progression; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Medical Records; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine	2009
Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. Journal of experimental & clinical cancer research : CR, 2009, May-27, Volume: 28 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Dose Fractionation, Radiation; Doxorubicin; Drug Resistance, Neoplasm; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Paclitaxel; Radiation Tolerance; Tumor Cells, Cultured; X-Rays	2009
Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines. Head & neck, 2010, Volume: 32, Issue:5 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Head and Neck Neoplasms; Humans; Phosphorylation; Replication Protein A	2010
Methylation induced gene silencing of HtrA3 in smoking-related lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Jan-15, Volume: 16, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Cells, Cultured; Cisplatin; DNA Methylation; Drug Resistance, Neoplasm; Etoposide; Gene Silencing; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nitrosamines; Serine Endopeptidases; Smoking	2010
Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling. PloS one, 2010, Jul-06, Volume: 5, Issue:7 Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; beta Catenin; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Cell Line, Tumor; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Neoplasm Proteins; Pyrazines; Signal Transduction; Stem Cells; Wnt Proteins	2010
Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma. Cancer gene therapy, 2010, Volume: 17, Issue:11 Topics: Adenoviridae; Adenovirus E1B Proteins; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Oncolytic Virotherapy; Virus Replication	2010
Cisplatin combination chemotherapy induces oxidative stress in advance non small cell lung cancer patients. Asian Pacific journal of cancer prevention : APJCP, 2010, Volume: 11, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Lipid Peroxidation; Lung Neoplasms; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Survival Rate; Treatment Outcome	2010
Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients. Pathology oncology research : POR, 2011, Volume: 17, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Prospective Studies; Real-Time Polymerase Chain Reaction; RNA, Messenger; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine	2011
The bacterial protein azurin enhances sensitivity of oral squamous carcinoma cells to anticancer drugs. Yonsei medical journal, 2011, Volume: 52, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Azurin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin B1; Drug Synergism; Etoposide; Fluorouracil; Humans; Mouth Neoplasms; Tumor Suppressor Protein p53	2011
Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells. Molecular cancer, 2011, Jul-31, Volume: 10 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Caspase 8; Cell Line, Tumor; DNA-Binding Proteins; Drug Evaluation, Preclinical; Enzyme Activation; Etoposide; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Mitochondria; Nuclear Proteins; RNA, Small Interfering; Squamous Cell Carcinoma of Head and Neck; Transfection; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2011
QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells. Cancer science, 2012, Volume: 103, Issue:1 Topics: Adenocarcinoma; Antigens, Neoplasm; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Caspase 3; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Flow Cytometry; Humans; Lung Neoplasms; Piperidines; Podophyllotoxin; Poly(ADP-ribose) Polymerases; RNA, Small Interfering; Topoisomerase II Inhibitors; Tumor Cells, Cultured	2012
Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:11 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Time Factors; Tomography, X-Ray Computed	2011
Vaginal cancer following etoposide-containing chemotherapy for metastatic gestational trophoblastic tumour. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2012, Volume: 32, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Hydatidiform Mole; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary; Pregnancy; Uterine Neoplasms; Vaginal Neoplasms	2012
Cisplatinum combined with etoposide. Effective therapy for metastasised squamous-cell carcinoma of the cervix. European journal of gynaecological oncology, 2011, Volume: 32, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Uterine Cervical Neoplasms	2011
Head and neck region consolidation radiotherapy and prophylactic cranial irradiation with hippocampal avoidance delivered with helical tomotherapy after induction chemotherapy for non-sinonasal neuroendocrine carcinoma of the upper airways. Radiation oncology (London, England), 2012, Feb-15, Volume: 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cisplatin; Cranial Irradiation; Etoposide; Head and Neck Neoplasms; Hippocampus; Humans; Induction Chemotherapy; Male; Middle Aged; Organ Sparing Treatments; Remission Induction; Respiratory Tract Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2012
HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer. Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Electrophoresis, Gel, Two-Dimensional; Etoposide; Follow-Up Studies; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Mitochondrial Trifunctional Protein; Mitochondrial Trifunctional Protein, alpha Subunit; Multienzyme Complexes; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Small Cell Lung Carcinoma; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured	2011
Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cross-Sectional Studies; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Survival Rate	2012
Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomes. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hemorrhage; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prognosis; Pulmonary Embolism; Retrospective Studies; Risk Factors; Survival Rate	2012
The ubiquitin-conjugating enzyme E2-EPF is overexpressed in cervical cancer and associates with tumor growth. Oncology reports, 2012, Volume: 28, Issue:4 Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Paclitaxel; Promoter Regions, Genetic; Reference Values; RNA, Small Interfering; Topoisomerase I Inhibitors; Topoisomerase Inhibitors; Topotecan; Ubiquitin-Conjugating Enzymes; Uterine Cervical Neoplasms	2012
[Effect of preoperative concurrent chemo-radiotherapy for thymic carcinoma]. Kyobu geka. The Japanese journal of thoracic surgery, 2002, Volume: 55, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Male; Middle Aged; Preoperative Care; Radiotherapy Dosage; Remission Induction; Thymoma; Thymus Neoplasms	2002
The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis, 2002, Volume: 23, Issue:11 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Cycle; Ceramides; Enzyme Activation; Enzyme Inhibitors; Etoposide; Female; Flavonoids; HeLa Cells; Humans; Imidazoles; MAP Kinase Signaling System; Microtubules; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Paclitaxel; Pyridines; Skin Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay	2002
Squamous cell carcinoma of the colon with an elevated serum squamous cell carcinoma antigen responding to combination chemotherapy. Clinical colorectal cancer, 2001, Volume: 1, Issue:1 Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Colonic Neoplasms; Etoposide; Fatal Outcome; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Serpins; Tomography, X-Ray Computed	2001
Etoposide-mediated sensitization of squamous cell carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced loss in mitochondrial membrane potential. Oral oncology, 2003, Volume: 39, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; bcl-X Protein; Carcinoma, Squamous Cell; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Humans; Intracellular Membranes; Ligands; Membrane Glycoproteins; Membrane Potentials; Mitochondria; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2003
[Thymic carcinoma (mixed small cell undifferentiated squamous cell carcinoma); report of a case]. Kyobu geka. The Japanese journal of thoracic surgery, 2003, Volume: 56, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasms, Multiple Primary; Thymectomy; Thymus Neoplasms	2003
Overexpression of interleukin-2 receptor alpha in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability. Journal of cellular biochemistry, 2003, Jul-01, Volume: 89, Issue:4 Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Division; Cell Line, Transformed; Cyclin-Dependent Kinases; Cyclins; Cysteine Endopeptidases; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Head and Neck Neoplasms; Humans; Interleukin-2 Receptor alpha Subunit; Janus Kinase 3; Multienzyme Complexes; Paclitaxel; Proteasome Endopeptidase Complex; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Receptors, Interleukin; Tumor Cells, Cultured; Ubiquitin	2003
[A case of advanced thymic cancer successfully treated with neoadjuvant intra-arterial infusion chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Neoadjuvant Therapy; Thymectomy; Thymus Neoplasms; Vincristine	2003
[Tumor staging with PET/CT. Detection of a second tumor]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2004, Volume: 176, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biopsy; Bronchoscopy; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Hypopharyngeal Neoplasms; Hypopharynx; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Radiography, Thoracic; Radiotherapy, Adjuvant; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
Metastatic lung disease to the central nervous system: in vitro response to chemotherapeutic agents. Journal of neuro-oncology, 2004, Volume: 66, Issue:1-2 Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Squamous Cell; Central Nervous System Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Tumor Cells, Cultured	2004
Bifocal esophageal and rectal cancer palliatively treated with argon plasma coagulation. Surgical endoscopy, 2004, Volume: 18, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Argon; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Doxorubicin; Esophageal Neoplasms; Etoposide; Fatal Outcome; Humans; Light Coagulation; Male; Microsurgery; Neoplasms, Second Primary; Palliative Care; Rectal Neoplasms	2004
Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line. Journal of immunology (Baltimore, Md. : 1950), 2004, May-15, Volume: 172, Issue:10 Topics: Adjuvants, Immunologic; Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Chromans; Cytokines; Etoposide; Humans; Interleukin-8; KB Cells; Mitomycin; NF-kappa B; Oxidative Stress; Phospholipid Ethers; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Transduction, Genetic	2004
Response of early stage bulky cervical squamous carcinoma to preoperative adjuvant chemotherapy. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2004, Volume: 19, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Preoperative Care; Uterine Cervical Neoplasms; Vincristine	2004
2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines. Cancer biology & therapy, 2004, Volume: 3, Issue:9 Topics: Adenosine Triphosphate; Antimetabolites; Antineoplastic Agents, Phytogenic; Benzimidazoles; Brain Neoplasms; Camptothecin; Carcinoma, Squamous Cell; Cell Survival; Deoxyglucose; DNA Damage; Drug Interactions; Enzyme Inhibitors; Etoposide; Glioma; Humans; Radiation-Sensitizing Agents; Topoisomerase Inhibitors; Tumor Cells, Cultured	2004
[A case of thymic carcinoma responding to combination chemotherapy with nedaplatin, etoposide, and ifosfamide]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Organoplatinum Compounds; Thymus Neoplasms; Tomography, X-Ray Computed	2005
Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy. Cancer biology & therapy, 2005, Volume: 4, Issue:7 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cisplatin; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Humans; In Situ Nick-End Labeling; Inhibitor of Apoptosis Proteins; Laryngeal Neoplasms; Microtubule-Associated Proteins; Neoplasm Proteins; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survivin; Tongue Neoplasms; Tumor Cells, Cultured	2005
[Thymic cancer effectively treated by combination chemotherapy of carboplatin and etoposide with concurrent radiotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Thymectomy; Thymus Neoplasms	2005
Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer research, 2006, Feb-01, Volume: 66, Issue:3 Topics: Apoptosis; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Enzyme Activation; Etoposide; Heat-Shock Proteins; Humans; Molecular Chaperones; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proteomics; RNA Interference; Up-Regulation	2006
Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro. Oncology reports, 2006, Volume: 15, Issue:4 Topics: Antigens, CD20; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; CD40 Antigens; Cell Survival; Clone Cells; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Etoposide; Female; Flow Cytometry; Fluorouracil; Humans; Integrin alpha1; Integrin alpha6; Irinotecan; Mitomycin; Uterine Cervical Neoplasms; X-Rays	2006
Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines. Journal of medical and dental sciences, 2006, Volume: 53, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Caspase 8; Caspases; Cell Line, Tumor; Chromones; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Membrane Glycoproteins; Morpholines; Mutation; Phosphorylation; Proto-Oncogene Proteins c-akt; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53	2006
[Collision cancer of squamous cell carcinoma and small cell carcinoma of the lung; report of a case]. Kyobu geka. The Japanese journal of thoracic surgery, 2006, Volume: 59, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Irinotecan; Lung Neoplasms; Lymph Node Excision; Male; Neoplasms, Multiple Primary; Pneumonectomy	2006
FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis. Journal of cellular biochemistry, 2007, Jan-01, Volume: 100, Issue:1 Topics: Antibodies; Apoptosis; Carcinoma, Squamous Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Survival; Cyclohexylamines; Etoposide; fas Receptor; Head and Neck Neoplasms; Humans; NF-kappa B; Protein Phosphatase 1; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 13; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Signal Transduction; Staurosporine; Up-Regulation; Vanadates	2007
Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder. International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Humans; Irinotecan; Male; Neoadjuvant Therapy; Remission Induction; Urinary Bladder Neoplasms	2006
[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:11 Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Particle Accelerators; Radioisotope Teletherapy; Radiotherapy, Conformal; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis	2006
[Superficial small cell carcinoma of esophagus treated by endoscopic mucosal resection combined with chemoradiotherapy--a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Esophagoscopes; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Mucous Membrane	2007
The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer. Archives of otolaryngology--head & neck surgery, 2007, Volume: 133, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Topoisomerases, Type II; Etoposide; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Hyaluronic Acid; Male; Phosphorylation; Signal Transduction; Type C Phospholipases	2007
[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer]. Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:4 Topics: Adult; Antineoplastic Agents; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Uterine Cervical Neoplasms	2007
Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens. Japanese journal of clinical oncology, 2007, Volume: 37, Issue:8 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclin D1; Cyclophosphamide; Doxorubicin; ErbB Receptors; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Male; Prognosis; Proliferating Cell Nuclear Antigen; Tumor Suppressor Protein p53	2007
Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Middle Aged	1984
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer. Medical and pediatric oncology, 1981, Volume: 9, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin	1981
[Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study]. Onkologie, 1983, Volume: 6, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged	1983
Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Cancer treatment reports, 1984, Volume: 68, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Podophyllotoxin; Uterine Cervical Neoplasms	1984
cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trial. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pulmonary Atelectasis; Time Factors	1984
Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin. Cancer treatment reports, 1984, Volume: 68, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Thrombocytopenia	1984
Establishment of an etoposide-resistant human epithelial tumour cell line in vitro: characterization of patterns of cross-resistance and drug sensitivities. International journal of cancer, 1984, May-15, Volume: 33, Issue:5 Topics: Carcinoma, Squamous Cell; Cell Line; Cisplatin; DNA, Neoplasm; Drug Resistance; Etoposide; Fluorouracil; Humans; Podophyllotoxin; Teniposide; Tongue Neoplasms; Vincristine; X-Rays	1984
Phase II study of etoposide in the treatment of esophageal carcinoma. Cancer treatment reports, 1983, Volume: 67, Issue:4 Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Esophageal Neoplasms; Etoposide; Humans; Middle Aged; Podophyllotoxin	1983
Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium). Cancer, 1982, Dec-15, Volume: 50, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Middle Aged; Podophyllotoxin	1982
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience. American journal of clinical oncology, 1982, Volume: 5, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines	1982
Phase II trial of VP-16-213 in non-small-cell lung cancer. American journal of clinical oncology, 1982, Volume: 5, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Squamous Cell; Digestive System; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin	1982
Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer. Oncology, 1981, Volume: 38, Issue:5 Topics: Brain Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Pilot Projects; Podophyllotoxin; Sugar Alcohols	1981
[Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213]. Schweizerische medizinische Wochenschrift, 1981, Sep-05, Volume: 111, Issue:36 Topics: Adenocarcinoma; Body Weight; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Etoposide; Humans; Leukocyte Count; Lung Neoplasms; Podophyllotoxin; Vomiting	1981
[Experimental and clinical study on chemotherapy for cervical adenocarcinoma]. Nihon Sanka Fujinka Gakkai zasshi, 1995, Volume: 47, Issue:4 Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Uterine Cervical Neoplasms	1995
Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions. Journal of medical virology, 1995, Volume: 46, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; DNA Primers; DNA, Viral; Esophageal Neoplasms; Esophagus; Etoposide; Humans; Molecular Sequence Data; Papillomaviridae; Polymerase Chain Reaction	1995
[A case report: complete remission of stage IV uterine cervix carcinoma by immuno-chemotherapy with intraarterial infusion using implantable reservoir system]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Hysterectomy; Immunotherapy; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lymph Node Excision; Picibanil; Remission Induction; Tegafur; Uracil; Uterine Cervical Neoplasms	1995
Induction chemotherapy with cisplatin, etoposide, and mitomycin-C (PEM) regimen in advanced cases with cancer of pharynx and oral cavity. Auris, nasus, larynx, 1995, Volume: 22, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Remission Induction	1995
Effects of mitomycin-C and etoposide in cell culture and in nude mice: the role of G-CSF mutein. Cancer investigation, 1993, Volume: 11, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Laryngeal Neoplasms; Mice; Mice, Nude; Mitomycin; Tumor Cells, Cultured	1993
Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:2 Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Cell Line; Cell Survival; DNA Damage; DNA, Neoplasm; Drug Synergism; Etoposide; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Male; Methotrexate; Mice; Mice, Inbred C3H; Novobiocin; Ornithine; Pterins; Topoisomerase II Inhibitors; Trimetrexate; Tumor Cells, Cultured	1995
Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice. Cellular and molecular biology (Noisy-le-Grand, France), 1995, Volume: 41, Issue:1 Topics: Animals; Cachexia; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cell Division; Combined Modality Therapy; Drug Interactions; Drug Screening Assays, Antitumor; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypopharyngeal Neoplasms; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Neoplastic Stem Cells; Recombinant Proteins; Transplantation, Heterologous; Tumor Necrosis Factor-alpha	1995
Assessment of response of esophageal carcinoma to induction chemotherapy. Endoscopy, 1993, Volume: 25, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophagus; Etoposide; Female; Humans; Male; Middle Aged; Prospective Studies; Tomography, X-Ray Computed; Ultrasonography	1993
[Treatment of unresectable non-small cell lung cancer (NSCLC) with carboplatin and chronic daily administration of oral etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:1 Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged	1994
Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. The Annals of thoracic surgery, 1993, Volume: 56, Issue:2 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Postoperative Complications; Prospective Studies; Radiotherapy Dosage; Survival Rate	1993
[A case of drug induced pneumonitis caused by oral etoposide]. Nihon Kyobu Shikkan Gakkai zasshi, 1993, Volume: 31, Issue:7 Topics: Administration, Oral; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Pulmonary Fibrosis	1993
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Teniposide; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	1993
[Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:12 Topics: Adenocarcinoma; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granisetron; Humans; Indazoles; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Nausea; Vindesine; Vomiting	1993
Increased cytotoxicity of squamous cell carcinoma of the head and neck by combining cisplatin with VP-16 and ciprofloxacin. The Laryngoscope, 1993, Volume: 103, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Survival; Ciprofloxacin; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Head and Neck Neoplasms; Humans; Tumor Cells, Cultured	1993
[Etoposide, pirarubicin and cisplatin(ETP) combined therapy of inoperable head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged	1993
[Disease-free survival in a patient with squamous cell lung carcinoma following complete response with the combination chemotherapy of cisplatin and etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:7 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Prognosis; Remission Induction; Tegafur; Uracil	1993
[A case of superior vena cava syndrome treated with combination radiation and CRE (CBDCA and VP-16) therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Male; Radiotherapy Dosage; Superior Vena Cava Syndrome	1996
High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Gynecologic oncology, 1996, Volume: 61, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Radiation Injuries; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms	1996
Epidermal growth factor regulates topoisomerase II activity and drug sensitivity in human KB cells. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1996, Volume: 114, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Squamous Cell; Catalysis; Cell Division; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Screening Assays, Antitumor; Epidermal Growth Factor; Etoposide; Head and Neck Neoplasms; Humans; KB Cells; Tumor Cells, Cultured	1996
[Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms	1996
[Effect of calmodulin antagonist on chemosensitivity of primary cultured lung cancer cells]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1995, Volume: 17, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Calmodulin; Carcinoma, Squamous Cell; Doxorubicin; Drug Synergism; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Trifluoperazine; Tumor Cells, Cultured; Vincristine	1995
mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines. Cytotechnology, 1996, Volume: 19, Issue:3 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Carcinoma, Squamous Cell; Codon; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Exons; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neoplasm Proteins; Phenotype; Plasmids; Polymerase Chain Reaction; RNA, Antisense; RNA, Catalytic; RNA, Messenger; RNA, Neoplasm; Substrate Specificity; Transfection; Tumor Cells, Cultured; Vincristine	1996
Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines. Cytotechnology, 1996, Volume: 19, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Clone Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; HeLa Cells; Humans; Laryngeal Neoplasms; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Radiation Tolerance; Selection, Genetic; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vincristine	1996
Topoisomerase II alpha content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines. Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:3 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Isoenzymes; Lung Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1997
[Early results of chemotherapy in patients with non-small cell lung cancer]. Pneumonologia i alergologia polska, 1996, Volume: 64, Issue:11-12 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Remission Induction; Treatment Outcome	1996
[Comparison of induction chemotherapy before radiotherapy and radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1997, Volume: 173, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Time Factors	1997
Multimodality treatment in the management of esophageal cancer: neoadjuvant chemoradiotherapy followed by transhiatal esophagectomy. Maryland medical journal (Baltimore, Md. : 1985), 1997, Volume: 46, Issue:9 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Treatment Outcome	1997
Neuron-specific enolase (NSE) serum level in non small cell lung cancer--can it be an indicator of tumour chemosensitivity? Roczniki Akademii Medycznej w Bialymstoku (1995), 1997, Volume: 42 Suppl 1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Differentiation; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Proteins; Phosphopyruvate Hydratase; Predictive Value of Tests; Treatment Outcome; Vincristine	1997
[Augmented antitumor activity in combination chemotherapy of nedaplatin with etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Synergism; Etoposide; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Organoplatinum Compounds; Weight Loss	1998
Clonal analysis of cancer cells that survived anticancer drug treatment. Osaka city medical journal, 1997, Volume: 43, Issue:2 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; Cell Survival; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Humans; Irinotecan; Tumor Cells, Cultured; Uterine Cervical Neoplasms	1997
[CDDP-resistant early recurrent uterine cervical cancer successfully treated with low-dose oral etoposide: a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:6 Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Remission Induction; Uterine Cervical Neoplasms	1998
Pre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:5 Topics: Adenocarcinoma; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Preoperative Care; Survival Analysis; Treatment Outcome	1998
Rapid progression of squamous cell carcinoma of the cervix after hyperbaric oxygenation. European journal of obstetrics, gynecology, and reproductive biology, 1999, Volume: 82, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Hyperbaric Oxygenation; Lymph Node Excision; Lymphatic Diseases; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed; Uterine Cervical Neoplasms	1999
Makaluvamines vary in ability to induce dose-dependent DNA cleavage via topoisomerase II interaction. Anti-cancer drugs, 1999, Volume: 10, Issue:1 Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; DNA; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Pyrroles; Quinolones; Topoisomerase II Inhibitors	1999
Pharmacokinetics of etoposide after intrathoracic instillation to lung cancer patients with pleural effusion. International journal of clinical pharmacology and therapeutics, 1999, Volume: 37, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Pleural Effusion, Malignant	1999
[Evaluation of antitumor activity of etoposide administered orally for 21 consecutive days against human uterine cancer subcutaneous and/or orthotopic xenografts in nude mice]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:9 Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Floxuridine; Humans; Irinotecan; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Skin; Transplantation, Heterologous; Uterine Neoplasms	1999
[Usefulness of combination therapy with expandable metallic stent replacement and FLEP chemotherapy (consisting of 5-FU, leucovorin, etoposide and cisplatin) for advanced esophageal cancer invading the bronchus: a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Invasiveness; Stents	1999
The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. British journal of cancer, 1999, Volume: 81, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; DNA, Complementary; Drug Resistance, Neoplasm; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Monomeric GTP-Binding Proteins; Neoplasm Proteins; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Oligonucleotides, Antisense; Survival Analysis; Survival Rate; Transcription Factors; Transfection; Treatment Outcome; Tumor Cells, Cultured	1999
The role of mitochondria in apoptosis induced in vitro. General physiology and biophysics, 1999, Volume: 18 Spec No Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Membrane; Energy Metabolism; Etoposide; Humans; Microscopy, Video; Mitochondria; Tumor Cells, Cultured; Xenobiotics	1999
Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients. International journal of radiation oncology, biology, physics, 1999, May-01, Volume: 44, Issue:2 Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Survival Analysis; Vinblastine	1999
[Histoculture drug response assay on non-small cell lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Mitomycin; Tumor Cells, Cultured	2000
Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus. American journal of clinical oncology, 2000, Volume: 23, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Deglutition Disorders; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Prognosis; Quality of Life; Survival Analysis	2000
[An successful case of combined daily oral administration of UFT and low-dose etoposide for multiple metastases of lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:7 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Multiple Primary; Tegafur; Uracil	2000
Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer. Cancer detection and prevention, 2000, Volume: 24, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Immunohistochemistry; Isoenzymes; Lung Neoplasms; Male; Middle Aged; Time Factors	2000
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival. Cancer immunology, immunotherapy : CII, 2000, Volume: 49, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Interleukin-2; Life Tables; Lung Neoplasms; Male; Middle Aged; Neoplasm Proteins; Remission Induction; Survival Analysis; Th1 Cells; Treatment Outcome	2000
Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay. Anti-cancer drugs, 2000, Volume: 11, Issue:10 Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Etoposide; Female; Humans; Luminescent Measurements; Paclitaxel; Topotecan; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vulvar Neoplasms	2000
Tumor-induced apoptosis of T cells: amplification by a mitochondrial cascade. Cancer research, 2000, Dec-15, Volume: 60, Issue:24 Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Bongkrekic Acid; Carbocyanines; Carcinoma, Squamous Cell; Carrier Proteins; Caspase 9; Caspases; Coculture Techniques; Cyclosporine; Cytochrome c Group; Cytosol; DNA; Enzyme Activation; Enzyme Inhibitors; Etoposide; fas Receptor; Fluorescent Antibody Technique; Fluorescent Dyes; Head and Neck Neoplasms; Humans; Jurkat Cells; Lymphocytes; Microscopy, Fluorescence; Mitochondria; Oligopeptides; Protein Transport; Subcellular Fractions; T-Lymphocytes; Tumor Cells, Cultured	2000
[Outpatient chemotherapy for advanced lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Docetaxel; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Rate; Taxoids	2001
Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer. Journal of experimental & clinical cancer research : CR, 2001, Volume: 20, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome	2001
TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells. Oncogene, 2002, Jan-10, Volume: 21, Issue:2 Topics: Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Carcinoma, Squamous Cell; Cloning, Molecular; DNA Fingerprinting; DNA-Binding Proteins; Dose-Response Relationship, Drug; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Kinetics; Lung Neoplasms; Membrane Glycoproteins; NF-kappa B; NF-KappaB Inhibitor alpha; Recombinant Proteins; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2002
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung. Cancer treatment reports, 1978, Volume: 62, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Time Factors	1978
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma]. Schweizerische medizinische Wochenschrift, 1977, Jul-02, Volume: 107, Issue:26 Topics: Adenocarcinoma; Anaplasia; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Vincristine	1977
[Pilot phase II trial of high-dose etoposide combined with cisplatin in the treatment of refractory lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Sarcoma	1992
Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response. Acta obstetricia et gynecologica Scandinavica, 1992, Volume: 71, Issue:4 Topics: Adenocarcinoma; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Middle Aged; Serpins; Trypsin Inhibitor, Kazal Pancreatic; Uterine Cervical Neoplasms	1992
Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer. Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1 Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Clinical Protocols; Clinical Trials, Phase II as Topic; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Remission Induction; Survival Rate	1992
Different sensitivities of human esophageal cancer cells to multiple anti-cancer agents and related mechanisms. Cancer, 1992, Nov-15, Volume: 70, Issue:10 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Western; Carcinoma, Squamous Cell; DNA Topoisomerases, Type II; Drug Resistance; Esophageal Neoplasms; Etoposide; Gene Expression; Glutathione Transferase; Humans; Membrane Glycoproteins; RNA, Neoplasm; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine; Vindesine	1992
[Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Methotrexate; Peplomycin; Tumor Cells, Cultured; Vincristine	1992
Treatment of recurrent and metastatic head and neck cancer with cisplatin/etoposide/bleomycin. Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 5 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Creatinine; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycins; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Survival Rate	1992
Activity of etoposide (VP-16) and teniposide (VM-26) in exponential and plateau phase human tumor cell cultures. Anti-cancer drugs, 1992, Volume: 3, Issue:3 Topics: Autoradiography; Carcinoma, Squamous Cell; Cell Line; Etoposide; Flow Cytometry; Humans; Teniposide; Thymidine; Tumor Cells, Cultured	1992
[Intra-arterial infusion chemotherapy of advanced bladder cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:10 Suppl Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Male; Prognosis; Urinary Bladder Neoplasms	1992
Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer research, 1991, Aug-01, Volume: 51, Issue:15 Topics: Carcinoma, Squamous Cell; DNA; DNA Topoisomerases, Type II; Etoposide; Humans; KB Cells; Mutation; Neoplasms; Phosphorylation; Tumor Cells, Cultured	1991
Clinical pharmacology and toxicity of low daily administration of oral etoposide in advanced lung cancer patients. Journal of clinical pharmacology, 1991, Volume: 31, Issue:12 Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged	1991
[Thermochemotherapy of prostatic cancer]. Hinyokika kiyo. Acta urologica Japonica, 1991, Volume: 37, Issue:8 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bleomycin; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Evaluation Studies as Topic; Humans; Hyperthermia, Induced; Male; Middle Aged; Peplomycin; Prostatic Neoplasms	1991
Reduced oral etoposide bioavailability in patients with advanced cancer of the head and neck. Journal of the National Cancer Institute, 1992, Mar-04, Volume: 84, Issue:5 Topics: Administration, Oral; Adult; Aged; Alcoholism; Biological Availability; Carcinoma, Squamous Cell; Etoposide; Head and Neck Neoplasms; Humans; Injections, Intravenous; Middle Aged	1992
Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment. International journal of radiation oncology, biology, physics, 1991, Volume: 20, Issue:2 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Regression Analysis; Survival Analysis	1991
[Adriamycin, cisplatin and etoposide combination chemotherapy in non-small cell lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Vomiting	1991
Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluation. American journal of clinical oncology, 1991, Volume: 14, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Remission Induction; Survival Rate; Time Factors	1991
[The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:6 Topics: Adenocarcinoma; Administration, Oral; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Humans; Infusions, Intravenous; Kidney; Leukopenia; Lung Neoplasms	1991
A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC). Journal of chemotherapy (Florence, Italy), 1990, Volume: 2, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Remission Induction	1990
Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro. Cancer research, 1990, Dec-01, Volume: 50, Issue:23 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Survival; Colchicine; Dipyridamole; Drug Resistance; Drug Synergism; Etoposide; Humans; In Vitro Techniques; Membrane Glycoproteins; Neoplasm Proteins; Verapamil; Vinblastine	1990
Activity of etoposide (VP-16) in human tumor cells under different growth conditions. International journal of radiation oncology, biology, physics, 1991, Volume: 20, Issue:2 Topics: Carcinoma, Squamous Cell; Cell Cycle; Drug Resistance; Etoposide; Flow Cytometry; Humans; Tumor Cells, Cultured	1991
[In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:4 Pt 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Leukemia, Myeloid; Methotrexate; Mitomycin; Mitomycins; Tumor Cells, Cultured; Uterine Cervical Neoplasms	1990
Phase II studies with carboplatin in non-small cell lung cancer. Seminars in oncology, 1990, Volume: 17, Issue:1 Suppl 2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Remission Induction; Survival Rate	1990
Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC). Medical oncology and tumor pharmacotherapy, 1990, Volume: 7, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate	1990
Phase II trial of etoposide and doxorubicin in advanced head and neck cancer. Medical and pediatric oncology, 1990, Volume: 18, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Inflammation; Leukocyte Count; Leukopenia; Mucous Membrane; Platelet Count; Remission Induction; Thrombocytopenia	1990
Relation between responses to induction chemotherapy and subsequent radiotherapy in advanced or multicentric squamous cell carcinomas of the head and neck. International journal of radiation oncology, biology, physics, 1990, Volume: 18, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged	1990
[Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosyluracil; Carcinoma, Squamous Cell; Child; Cisplatin; Cystadenocarcinoma; Cytarabine; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusion Pumps; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Teratoma	1990
Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Time Factors	1985
[The relationship between morphological manifestations and cell kinetic changes of human lung cancer cells after exposure to chemotherapeutic agents]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1986, Volume: 61, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents; Bleomycin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Cycle; Cell Line; Cisplatin; DNA, Neoplasm; Etoposide; Flow Cytometry; Humans; Lung Neoplasms; Peplomycin	1986
Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line. Cancer research, 1989, Mar-01, Volume: 49, Issue:5 Topics: Amsacrine; Carcinoma, Squamous Cell; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; Etoposide; Head and Neck Neoplasms; Humans; Tretinoin; Tumor Cells, Cultured	1989
Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells. Cancer research, 1985, Volume: 45, Issue:5 Topics: Animals; Bleomycin; Calmodulin; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; DNA Repair; Drug Synergism; Etoposide; Head and Neck Neoplasms; Humans; Leukemia L1210; Lidocaine; Mice	1985
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer]. Geburtshilfe und Frauenheilkunde, 1989, Volume: 49, Issue:12 Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Neoplasm Recurrence, Local; Organoplatinum Compounds; Prognosis; Serpins; Uterine Cervical Neoplasms	1989
Multimodality treatment of advanced head and neck carcinoma. Journal of the South Carolina Medical Association (1975), 1989, Volume: 85, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Pilot Projects	1989
Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer. Cancer treatment reports, 1987, Volume: 71, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Middle Aged	1987
Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma. International journal of radiation oncology, biology, physics, 1988, Volume: 15, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged	1988
Pilot study of a continuous five-day intravenous infusion of etoposide concomitant with cisplatin in selected patients with advanced cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Histiocytoma, Benign Fibrous; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Stomach Neoplasms; Tongue Neoplasms	1988
[Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine]. Onkologie, 1988, Volume: 11 Suppl 2 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vindesine	1988
[Hepatotoxicity with etoposide-ifosfamide combination therapy]. Onkologie, 1988, Volume: 11, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chemical and Drug Induced Liver Injury; Etoposide; Female; Humans; Ifosfamide; Liver Function Tests; Lung Neoplasms; Male; Middle Aged	1988
[Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16]. Strahlentherapie, 1985, Volume: 161, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine	1985
[A phase II study of oral VP-16 in primary lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:9 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anorexia; Capsules; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin	1985
[A phase II study of NK171 (etoposide)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:10 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin	1985
[A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Injections; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin	1986
[Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins	1986
Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study. Cancer, 1986, Sep-01, Volume: 58, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Middle Aged; Mitomycins; Pilot Projects	1986
Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer. Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged	1986
A phase II trial of a new combination chemotherapy (cisplatin, bleomycin, VP-16 and methylprednisolone) in advanced recurrent squamous cell carcinoma of the head and neck. Oncology, 1988, Volume: 45, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local	1988
Respiratory tract fistulae in recurrent aerodigestive cancers after chemotherapy. Cancer, 1988, Jan-15, Volume: 61, Issue:2 Topics: Bronchial Fistula; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiography	1988
Etoposide (VP16-213) in the treatment of advanced nasopharyngeal carcinoma. European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:4 Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms	1988
Effective management of extremity cancers using cisplatin and etoposide in isolated limb perfusions. Journal of surgical oncology, 1987, Volume: 35, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Etoposide; Female; Humans; Leg; Liposarcoma; Male; Melanoma; Middle Aged; Soft Tissue Neoplasms	1987
Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study. Cancer treatment reports, 1987, Volume: 71, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Vaginal Neoplasms; Vulvar Neoplasms	1987
Pharmacokinetics of high dose etoposide (VP 16-213). European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Saliva; Testicular Neoplasms	1986
Phase II trial of VP16-213 in squamous cell carcinoma of the head and neck. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:5 Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged	1987
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:5 Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Prognosis; Serum Albumin; Vinblastine	1986
Phase II trial of chemotherapy with cisplatin and etoposide in non-small cell lung cancer. Cancer treatment reports, 1986, Volume: 70, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged	1986
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lung. Cancer treatment reports, 1986, Volume: 70, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged	1986
Paroxysmal supraventricular tachycardia during treatment with cisplatin and etoposide combination. Oncology, 1986, Volume: 43, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Electrocardiography; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Tachycardia, Paroxysmal	1986
[Sensitivity to etoposide in cultured cells from cervical squamous cell carcinoma]. Nihon Sanka Fujinka Gakkai zasshi, 1986, Volume: 38, Issue:11 Topics: Carcinoma, Squamous Cell; Cell Division; Cells, Cultured; Drug Resistance; Etoposide; Female; Humans; Kinetics; Uterine Cervical Neoplasms	1986
Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neck. Cancer treatment reports, 1987, Volume: 71, Issue:3 Topics: Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Neoplasm Staging	1987
The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung. Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:1 Topics: Animals; Carcinoma, Squamous Cell; Cell Cycle; Cell Line; Cell Survival; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Lung Neoplasms; Podophyllotoxin; Teniposide	1987
Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study Group. Cancer treatment reports, 1986, Volume: 70, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Vindesine	1986
Cisplatin, etoposide, and radiotherapy in regional inoperable squamous cell carcinoma of the bronchus. Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Middle Aged	1985
Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer. American journal of clinical oncology, 1985, Volume: 8, Issue:5 Topics: Alopecia; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Leukopenia; Lymphatic Metastasis; Podophyllotoxin	1985